Radboud University Medical Center
🇳🇱Netherlands
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.radboudumc.nl
Dose Individualization of Pemetrexed - IMPROVE-III
- First Posted Date
- 2018-08-31
- Last Posted Date
- 2022-05-10
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT03655834
- Locations
- 🇳🇱
Antoni van Leeuwenhoek, Amsterdam, Netherlands
🇳🇱Maastricht University Medical centre, Maastricht, Netherlands
🇳🇱Radboud university medical centre, Nijmegen, Netherlands
Nationwide Implementation of Standardized Structured Reporting
- Conditions
- Standardized Structured Reporting
- Interventions
- Behavioral: Implementation tools
- First Posted Date
- 2018-08-28
- Last Posted Date
- 2018-08-28
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT03649126
- Locations
- 🇳🇱
Radboud University Nijmegen Medical Center, Nijmegen, Gelderland, Netherlands
Response of Immune System to Flu Vaccination in PHTS
Not Applicable
- Conditions
- PTEN Hamartoma Tumor Syndrome
- Interventions
- Biological: Influvac Tetra
- First Posted Date
- 2018-08-15
- Last Posted Date
- 2018-08-15
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT03630523
PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer
Recruiting
- Conditions
- Endometrial Cancer RecurrentEndometrial Cancer Stage IIIEndometrial Cancer Stage IV
- Interventions
- Drug: Hormonal Antineoplastics
- First Posted Date
- 2018-08-09
- Last Posted Date
- 2023-01-18
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 150
- Registration Number
- NCT03621904
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Netherlands
Dutch Intracerebral Hemorrhage Surgery Trial Pilot Study
Not Applicable
Completed
- Conditions
- Surgical Procedures, Minimally InvasiveIntracerebral Hemorrhage
- Interventions
- Device: Minimally-invasive endoscopy-guided surgery
- First Posted Date
- 2018-08-01
- Last Posted Date
- 2022-10-13
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 169
- Registration Number
- NCT03608423
- Locations
- 🇳🇱
Haaglanden Medical Center, Den Haag, Netherlands
🇳🇱Academic Medical Center, Amsterdam, Netherlands
🇳🇱Maastricht University Medical Center, Maastricht, Netherlands
The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Early Quality of Recovery
Phase 4
Completed
- Conditions
- SurgeryNeuromuscular BlockadePneumoperitoneum
- Interventions
- Procedure: Low pressure pneumoperitoneumDrug: Rocuronium Bromide
- First Posted Date
- 2018-08-01
- Last Posted Date
- 2021-10-28
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 178
- Registration Number
- NCT03608436
- Locations
- 🇳🇱
Canisius Wilhelmina Hospital, Nijmegen, Gelderland, Netherlands
🇳🇱Martini general hospital, Groningen, Netherlands
🇳🇱Maxima Medisch Centrum, Veldhoven, Netherlands
The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Innate Immune Homeostasis.
Phase 4
Completed
- Conditions
- PneumoperitoneumSurgeryImmune SuppressionNeuromuscular Blockade
- Interventions
- Procedure: Low pressure pneumoperitoneumDrug: Rocuronium bromide
- First Posted Date
- 2018-06-28
- Last Posted Date
- 2021-11-03
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT03572413
- Locations
- 🇳🇱
Canisius Wilhelmina Hospital, Nijmegen, Gelderland, Netherlands
Effect of Dapagliflozin on IAH in T1DM
Phase 2
Completed
- Conditions
- HypoglycemiaDiabetes Mellitus, Type 1Hypoglycemia Unawareness
- Interventions
- Drug: Placebo oral capsuleDrug: Dapagliflozin
- First Posted Date
- 2018-06-14
- Last Posted Date
- 2020-03-23
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT03556033
- Locations
- 🇳🇱
Radboud university medical center, Nijmegen, Netherlands
89Zr-girentuximab ) Dosimetry in CCRC Study - ZIR-DOSE
Phase 1
Completed
- Conditions
- Clear Cell Renal Carcinoma
- Interventions
- Diagnostic Test: 89Zr-Girentuximab
- First Posted Date
- 2018-06-14
- Last Posted Date
- 2019-04-01
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT03556046
- Locations
- 🇳🇱
Radboud University, Nijmegen, Netherlands
Pharmacogenetics Informed Tricyclic Antidepressant Dosing (PITA)
Phase 4
Completed
- Conditions
- Depressive Disorder, Major
- Interventions
- Drug: TCA treatment
- First Posted Date
- 2018-06-07
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 125
- Registration Number
- NCT03548675
- Locations
- 🇳🇱
Radboudumc Dept of Psychiatry, Nijmegen, Netherlands
© Copyright 2025. All Rights Reserved by MedPath